KARUNA THERAPEUTICS INC (KRTX)

US48576A1007 - Common Stock

329.83  +0.09 (+0.03%)

After market: 329.83 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
654.00K10.64M36.96M0.000.00
Operating Expenses
495.43M300.31M180.82M71.82M45.41M
Research and Development
364.10M224.25M128.20M43.41M24.54M
Selling, General, and Administrative Expenses
131.33M76.07M52.62M28.41M20.87M
Operating Income
-494.78M-289.68M-143.86M-71.82M-45.41M
Interest Income/Expense
61.18M14.18M500.00K3.31M1.45M
Other Income/Expense
588.00K580.00K250.00KN/AN/A
Non Recurring Items
0.000.00-700.00KN/AN/A
Income Before Taxes
-433.01M-274.92M-143.80M-68.51M-43.96M
Income Tax
670.00K1.42M10.00K40.00K0.00
Net Income
-433.68M-276.34M-143.81M-68.55M-43.96M
EBITDA
-493.08M-288.57M-143.35M-71.67M-45.35M
 
Per Share Data
EPS Diluted Total Ops
-11.73-8.74-4.94-2.59-1.69
Non GAAP EPS
-11.72-8.72-4.90-2.58N/A
 
Statistics
Profit Margin
-66311.93%-2597.18%-389.10%N/AN/A
Operating Profit Margin
-75653.98%-2722.56%-389.23%N/AN/A

All data in USD

Charts